Vasoplegic Syndrome in Cardiac Surgery

Le Syndrome vasoplégique en Post-opératoire de Chirurgie Cardiaque: étude de Construction et de Validation d'un Score prédictif (Etude ISYVACC).

NCT03281317•Centre Hospitalier Universitaire, Amiens

View on ClinicalTrials.gov

Summary

Vasoplasmic syndrome in cardiac surgery is one of the major postoperative complications.This syndrome is characterized by persistent low blood pressure despite an optimization of preload and inotropism.

Eligibility

Age

18 - 100 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All patients undergoing cardiac surgery with extracorporeal circulation
•Patients covered by a social insurance system.
•Patients who have given oral consent to participate after full information

Exclusion Criteria

•Cardiac graft.
•Preoperative ECMO / ECLS.
•Cardiac assistance.
•Minor,
•Patient deprived of liberty, or under safeguard of justice.

Locations (1)

CHU Amiens Picardie

Amiens, France

Key Dates

Start Date

December 15, 2017

Primary Completion Date

December 15, 2023

Completion Date

December 15, 2024

Last Updated

April 10, 2024

Enrollment

1,113

ESTIMATED participants

Conditions

Vasoplegic Syndrome of Cardiac Surgery

Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery

NCT06934798

Vasoplegic Syndrome of Cardiac Surgery

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 10, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions